NovoCure Limited (NVCR)
(Real Time Quote from BATS)
$17.97 USD
+0.07 (0.39%)
Updated Aug 19, 2024 03:43 PM ET
After-Market: $18.10 +0.13 (0.72%) 4:06 PM ET
2-Buy of 5 2
D Value C Growth A Momentum C VGM
Earnings News For NVCR
-
NovoCure: Q2 Earnings Snapshot
-
NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates
-
Novocure Reports Second Quarter 2024 Financial Results
-
NovoCure: Q1 Earnings Snapshot
-
NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates
-
Novocure Reports First Quarter 2024 Financial Results
-
NovoCure (NVCR) Expected to Beat Earnings Estimates: Should You Buy?
-
NovoCure (NVCR) Reports Q4 Loss, Tops Revenue Estimates
-
NovoCure: Q4 Earnings Snapshot
-
NovoCure: Q4 Earnings Snapshot
-
Novocure Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
-
NovoCure (NVCR) Reports Q3 Loss, Misses Revenue Estimates
-
NovoCure: Q3 Earnings Snapshot
-
Novocure Reports Third Quarter 2023 Financial Results
-
NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates
-
NovoCure: Q2 Earnings Snapshot
-
Novocure Reports Second Quarter 2023 Financial Results
-
NovoCure (NVCR) Reports Q1 Loss, Lags Revenue Estimates
-
NovoCure: Q1 Earnings Snapshot
-
Novocure Reports First Quarter 2023 Financial Results
-
NovoCure (NVCR) Reports Q4 Loss, Misses Revenue Estimates
-
NovoCure: Q4 Earnings Snapshot
-
NovoCure: Q4 Earnings Snapshot
-
Novocure Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update
-
Analysts Estimate NovoCure (NVCR) to Report a Decline in Earnings: What to Look Out for